Market Tracker

09/30 5:16pm ET

Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

16.64
Delayed Data
As of 3:59pm ET
 +0.38 / +2.34%
Today’s Change
6.91
Today|||52-Week Range
18.00
+78.73%
Year-to-Date

Today’s Trading

Previous close16.26
Today’s open16.40
Day’s range16.20 - 17.26
Volume1,235,286
Average volume (3 months)767,671
Market cap$703.8M
Dividend yield--
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-270.91%
Earnings growth (this year)+98.89%
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+119.16%
P/E ratioNM
Price/Sales3.58
Price/Book5.23

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...+0.20+3.17%
INOInovio Pharmaceutica...+0.06+0.65%
ZIOPZIOPHARM Oncology In...+0.05+0.90%
HRTXHeron Therapeutics I...+0.13+0.76%
Data as of 4:00pm ET, 09/30/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$109.9M
Annual profit (last year)-$39.9M
Net profit margin-36.27%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
Chief Financial Officer, Treasurer &
Senior VP
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts